A carregar...
Adjuvant chemotherapy for stage II colon cancer: who really needs it
BACKGROUND: Although there is evidence that failure to reach the baseline of 12–13 lymph nodes in resected specimens is related to poor prognosis of patients with stage II colon cancer, and may be a marker of adjuvant therapy, the use of these markers remains controversial. The objective of this stu...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6087016/ https://ncbi.nlm.nih.gov/pubmed/30123000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S160886 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|